Costa Rica vs Cuba: Previously treated cases tested for RR-/MDR-TB
Costa Rica
62.0%
in 2024
Cuba
61.0%
in 2024
Costa Rica rank
135th
Cuba rank
136th
Previously treated cases tested for RR-/MDR-TB over time
- Costa Rica
- Cuba
How they compare
Costa Rica currently reports 62.0% against 61.0% in Cuba, a difference of 1.0%.
The two have swapped places 9 times across 16 shared years of data; in 2005 it was Cuba ahead.
Costa Rica ranks 135th and Cuba ranks 136th of 180 countries.
Across the 3 decades both report, Costa Rica averaged higher in 2 and Cuba in 1.
Head to head by decade
| Decade | Costa Rica | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 67.4% | 34.7% | 32.7% | Costa Rica |
| 2010s | 39.3% | 71.9% | 32.6% | Cuba |
| 2020s | 54.8% | 52.0% | 2.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Costa Rica or Cuba?
- Costa Rica, at 62.0% against 61.0% in Cuba as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Costa Rica and Cuba?
- 1.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Cuba?
- 16 years are reported by both, from 2005 to 2024.
- How do Costa Rica and Cuba rank globally for previously treated cases tested for rr-/mdr-tb?
- Costa Rica ranks 135th and Cuba ranks 136th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.